LLY Stock Hits New Record, Eli Lilly Valuation Pushes Past Berkshire Hathaway Ahead Of Q3 Earnings

According to The Fly, Goldman Sachs expects Lilly to beat Q3 earnings estimates and raise its outlook, citing stronger-than-expected Mounjaro growth outside the U.S. and Zepbound volume gains supported by Medicare’s GLP-1 Bridge program.